LSKL, Inhibitor of Thrombospondin TSP-1 2TFA
LSKL (2TFA) is a small molecule inhibitor of thrombospondin-1 (TSP-1) -mediated activation of TGF-β. This compound is a valuable research tool for studying TGF-β signaling pathways in fibrosis, cancer, and wound healing models, both in vitro and in vivo.
Product Specifications
Product Name Alternative
LSKL, Inhibitor of Thrombospondin TSP 1 acetate, LSKL, Inhibitor of Thrombospondin TSP1 acetate, LSKL, Inhibitor of Thrombospondin TSP-1 Acetate, Smad, TGF-b/Smad, TGFb, TGFbeta/Smad, TGF-beta, TGFbeta, TGF-β/Smad, TGFβ
Field of Research
Pharmacology & Drug Discovery, Stem Cell & Developmental Biology
Purity
≥98% (May vary between batches)
Solubility
DMSO:27.5 mg/mL (40.05 mM)
Smiles
CC (C) C[C@@H] (C (N) =O) NC ([C@H] (CCCCN) NC ([C@H] (CO) NC ([C@@H] (N) CC (C) C) =O) =O) =O.OC (C (F) (F) F) =O.OC (C (F) (F) F) =O
Molecular Formula
C25H44F6N6O9
Molecular Weight
686.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742853-100 1x 100 µL
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881081-100 1x 100 µL
CD45RO (190-2F2.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940017-500 1x 500 µL
Ep-CAM / CD326 (VU-1D9), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400679-500 1x 500 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details